VENOOCCLUSIVE DISEASE side effect
What is VENOOCCLUSIVE DISEASE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
VENOOCCLUSIVE DISEASE and Recently Reported Side Effects
VENOOCCLUSIVE DISEASE and 15 most Active Side Effect polls
VENOOCCLUSIVE DISEASE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with VENOOCCLUSIVE DISEASE
AMBISOME CLOFARABINE CLOLAR CYCLOPHOSPHAMIDE DACTINOMYCIN GEMZAR INTERFERON MELPHALAN PROGRAF THYMOGLOBULIN ZAVEDOSMelphalan Side Effects Report #5661267-5
Consumer or non-health professional from JAPAN reported MELPHALAN problem on Feb 28, 2008. Female patient, 13 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with BUSULPHAN, THIOTEPA, CYCLOPHOSPHAMIDE, TACROLIMUS, STEM CELL TRANSPLANT, METHOTREXATE. Patient recovered.
Melphalan Side Effects Report #5677169-4
MELPHALAN problem was reported by a Physician from JAPAN on Mar 17, 2008. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with MELPHALAN. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, . MELPHALAN dosage: 70MGM2 PER DAY. During the same period patient was treated with BUSULPHAN, THIOTEPA, CYCLOPHOSPHAMIDE, TACROLIMUS, STEM CELL TRANSPLANT, METHOTREXATE. Patient recovered.
Dactinomycin Side Effects Report #5601898-1
Consumer or non-health professional from UNITED STATES reported DACTINOMYCIN problem on Feb 15, 2007. Male patient, weighting 99.21 lb, was diagnosed with rhabdomyosarcoma and was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, . DACTINOMYCIN dosage: 2 MG;Q6W;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, BACTRIM DS, CELEBREX, MIRALAX, PALONOSETRON, VALTREX. Patient was hospitalized. Patient recovered.
Ambisome Side Effects Report #5776157-7
AMBISOME problem was reported by a Health Professional from JAPAN on June 04, 2008. Female patient, 19 years of age, was diagnosed with aspergillosis and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, weight increased, . AMBISOME dosage: 50 MG, UID/QD, IV NOS. During the same period patient was treated with URSO, FAMOTIDINE, NORVASC, MUCODYNE, POTASSIUM CHLORIDE, ACYCLOVIR, NEUPOGEN, MAGNESIUM SULPHATE. Patient recovered.
Prograf Side Effects Report #5705340-1
Physician from JAPAN reported PROGRAF problem on Mar 25, 2008. Male patient, 54 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, . PROGRAF dosage: 0.03 MG/KG, CONTINUOUS, IV DRIP. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, LENOGRASTIM. Patient died.
Zavedos Side Effects Report #5296500-5
ZAVEDOS problem was reported by a Consumer or non-health professional from AUSTRALIA on Apr 03, 2007. Female patient, weighting 126.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ZAVEDOS. After drug was administered, patient experienced the following problems/side effects: venoocclusive disease, . ZAVEDOS dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, AMPHOTERICIN B, MEROPENEM, TEICOPLANIN. Patient recovered.
Thymoglobulin Side Effects Report #5491379-0
Physician from AUSTRALIA reported THYMOGLOBULIN problem on Sept 28, 2007. Female patient was diagnosed with bone marrow transplant, immunosuppression and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, venoocclusive disease, . THYMOGLOBULIN dosage: 0.5 MG/KG QD. Patient died.
Gemzar Side Effects Report #5755483-1
GEMZAR problem was reported by a Physician from FRANCE on May 21, 2008. Male patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: hepatic failure, venoocclusive disease, . GEMZAR dosage: unknown. During the same period patient was treated with ELOXATIN. Patient was hospitalized. Patient recovered.
Clofarabine Side Effects Report #5744287-1
Physician from UNITED STATES reported CLOFARABINE problem on May 12, 2008. Male patient was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: pseudomonal sepsis, venoocclusive disease, . CLOFARABINE dosage: unknown. Patient died.
Cyclophosphamide Side Effects Report #5689598-3
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Mar 25, 2008. Male patient, child 2 years of age, was diagnosed with rhabdomyosarcoma, evidence based treatment and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, febrile neutropenia, venoocclusive disease, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with VINCRISTINE, DACTINOMYCIN, CEFEPIME, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.
Interferon Side Effects Report #5625458-1
Physician from UNITED STATES reported INTERFERON GAMMA problem on Jan 30, 2008. Female patient was diagnosed with lymphoma and was treated with INTERFERON GAMMA. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, venoocclusive disease, . INTERFERON GAMMA dosage: 0.025 MG/M2,QOD FOR 10 DOSES, SUBCUTANEOUS. During the same period patient was treated with PROLEUKIN, NEUPOGEN, NEORAL, CYCLOPHOSPHAMIDE. Patient recovered.
Cyclophosphamide Side Effects Report #5758225-9
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from SPAIN on June 02, 2008. Male patient, 42 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus antigen positive, graft versus host disease, venoocclusive disease, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with BUSULFAN, METHOTREXATE, CYCLOSPORINE, ISONIAZID. Patient recovered.
Clolar Side Effects Report #5760328-X
Physician from UNITED STATES reported CLOLAR problem on May 22, 2008. Female patient, 60 years of age, weighting 193.1 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: ascites, deep vein thrombosis, venoocclusive disease, . CLOLAR dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5762195-7
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from SPAIN on June 05, 2008. Male patient, 42 years of age, was diagnosed with bone marrow conditioning regimen and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus antigen positive, graft versus host disease, venoocclusive disease, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with BUSULFAN, METHOTREXATE, CYCLOSPORINE, ISONIAZID. Patient recovered.